RxDoctor Payments DataLook up a doctor →

Marc Bloomenstein, OD

Optometrist · Scottsdale, AZNPI 1568428910

Payments from drug & device makers

$2,268,480in general payments, 2019–2025

Across 2,214 payments — averaging $1024.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sight Sciences, Inc.$602K
  • Oyster Point Pharma, Inc.$309K
  • AbbVie$292K
  • Tarsus Pharmaceuticals, Inc.$288K
  • Sun Pharmaceutical Industries Inc.$231K
  • Bausch & Lomb Americas Inc.$202K
  • plus $345K from 26 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sight Sciences, Inc.85$601,921
Oyster Point Pharma, Inc.179$308,891
AbbVie(2 entities)566$292,015
Tarsus Pharmaceuticals, Inc.223$287,732
Sun Pharmaceutical Industries Inc.381$230,861
Bausch & Lomb Americas Inc.284$202,461
Kala Pharmaceuticals, Inc.157$114,557
Dompe US, Inc.70$48,382
Alcon71$42,186
Johnson & Johnson Surgical Vision, Inc.37$37,585
Thea Pharma Inc.13$18,698
Harrow Eye, LLC17$18,076
Bausch & Lomb, A Division Of Bausch Health US, LLC40$17,641
Alcon Research LLC6$9,015
Glaukos Corporation5$8,105
Reichert, Inc.14$7,900
Novartis23$5,081
Topcon Healthcare, Inc.3$4,500
Eyevance Pharmaceuticals LLC12$3,875
Shire North American Group Inc7$3,583
Tearlab Corp3$1,438
Biotissue Holdings Inc.3$1,345
Apellis Pharmaceuticals, Inc.1$1,179
Aerie Pharmaceuticals, Inc.1$1,062
Astellas Pharma US Inc1$136
Rxsight Inc4$86
Mallinckrodt Enterprises LLC2$59
Mallinckrodt Hospital Products Inc.2$52
Akorn Operating Company LLC1$24
Staar Surgical Company1$15
Johnson & Johnson Vision Care, Inc.1$11
Quidel Corporation1$8

How this compares

$2,268,480 in reported general payments places this provider in the 95th percentile of 1,134 optometrist providers in Arizona.

See all optometrist providers in Arizona →

Medicare billing

Part B allowed, 2024
$65,392
Medicare patients
449
Services billed
604

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in Scottsdale

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →